Kathryn Fitch, RN, MEd
Advertisement
Articles by Kathryn Fitch, RN, MEd
Screening commercially insured individuals for colorectal cancer is a high-value service, costing less per year of life saved than breast or cervical cancer screening.
Advertisement
Latest Updated Articles
- Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL
Published: March 10th 2022 | Updated:
- The Value of Colonoscopic Colorectal Cancer Screening of Adults Aged 50 to 64
Published: August 5th 2015 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
2
5 Expanded FDA Approvals From October
3
Trial Data Yield Risk-Based NRSTS Treatment Strategies
4
Global CKD Burden Nearly Doubles Since 1990, Reaching 788 Million Adults Worldwide
5
